Announcement Regarding the Inclusion of Company Products in the National Essential Medicines List (2026 Edition)

ST Bailing Co., Ltd.·July 10, 2026·2 pages

✨ AI Summary

Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. announced that 12 of its major products have been included in the National Essential Medicines List (2026 Edition), effective September 1, 2026. This inclusion is expected to facilitate product promotion across medical institutions and positively impact the company's long-term market development. However, the exact financial impact remains uncertain due to market and policy variables, and investors are advised to exercise caution.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002424 Stock Abbreviation: ST Bailing Announcement No.: 2026-048

Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd.

Announcement Regarding the Inclusion of Company Products in the National Essential Medicines List (2026 Edition)

The National Health Commission released the National Essential Medicines List (2026 Edition) on July 9, 2026, which will take effect on September 1, 2026. Following a review, Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has 12 major products currently on the market included in the National Essential Medicines List (2026 Edition). The details are as follows:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.